BDBM50085629 2-[8-(4-Chloro-phenyl)-8-oxo-octylsulfanyl]-5-(1-methyl-2-oxo-1,2-dihydro-pyridin-4-ylmethyl)-1H-pyrimidin-4-one::CHEMBL128727
SMILES: Cn1ccc(Cc2cnc(SCCCCCCCC(=O)c3ccc(Cl)cc3)[nH]c2=O)cc1=O
InChI Key: InChIKey=WFQWFYMRSSXQRP-UHFFFAOYSA-N
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
LDL-associated phospholipase A2 (Homo sapiens (Human)) | BDBM50085629 (2-[8-(4-Chloro-phenyl)-8-oxo-octylsulfanyl]-5-(1-m...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | 41 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description The compound was tested for inhibition of Lipoprotein-associated phospholipase A2 (Lp-PLA2) | Bioorg Med Chem Lett 10: 395-8 (2000) BindingDB Entry DOI: 10.7270/Q25X285S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
LDL-associated phospholipase A2 (Homo sapiens (Human)) | BDBM50085629 (2-[8-(4-Chloro-phenyl)-8-oxo-octylsulfanyl]-5-(1-m...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 72 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Curated by ChEMBL | Assay Description Inhibition of lipoprotein-associated phospholipase A2 (Lp-PLA2) | Bioorg Med Chem Lett 10: 395-8 (2000) BindingDB Entry DOI: 10.7270/Q25X285S | |||||||||||
More data for this Ligand-Target Pair |